← Back to Clinical Trials
Recruiting NCT07533188

NCT07533188 Patient Outcomes Following Kinematic and Functional Alignment in Robotic-Assisted Total Knee Arthroplasty With Randomized Insert Types

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07533188
Status Recruiting
Phase
Sponsor Singapore General Hospital
Condition Knee Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 240 participants
Start Date 2025-10-14
Primary Completion 2027-10-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Medial Stabilized InsertCruciate Retaining Insert

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 240 participants in total. It began in 2025-10-14 with a primary completion date of 2027-10-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate patient outcomes following robotic-assisted total knee arthroplasty using the VELYS system. Patients undergoing surgery will receive either kinematic alignment or functional alignment as determined by the operating surgeon as part of routine clinical care. Within each surgical technique group, patients will be randomly assigned to receive different implant insert types (medial stabilised or cruciate retaining) using a REDCap-based randomisation process. Patient-reported outcome measures will be collected before surgery and at follow-up time points after surgery to assess clinical outcomes.

Eligibility Criteria

\*Inclusion Criteria:\* * Patients undergoing robotic-assisted total knee arthroplasty using the VELYS system * Diagnosis of knee osteoarthritis requiring surgical intervention * Able to provide informed consent * Willing to complete patient-reported outcome measures \*\*Exclusion Criteria:\*\* * Patients undergoing revision knee arthroplasty * Presence of active infection * Inability to comply with follow-up assessments * Severe co-morbidities that may affect surgical outcomes or participation in the study

Frequently Asked Questions

Who can join the NCT07533188 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07533188 currently recruiting?

Yes, NCT07533188 is actively recruiting participants. Visit ClinicalTrials.gov or contact Singapore General Hospital to inquire about joining.

Where is the NCT07533188 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT07533188 clinical trial?

NCT07533188 is sponsored by Singapore General Hospital. The trial plans to enroll 240 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology